TherapeuticsMD, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| RUBRIC CAPITAL MANAGEMENT LP | 11/14/2025 | 1.19 M | $1.28 M | 0.00% | 10.30% |
| CLEARLINE CAPITAL LP | 11/14/2025 | 635.22 K | $682.86 K | 0.00% | 5.49% |
| VANGUARD GROUP INC | 11/07/2025 | 376.83 K | $399.44 K | -0.57% | 3.26% |
| TEJARA CAPITAL LTD | 11/04/2025 | 344.20 K | $370.02 K | -0.01% | 2.97% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 11/14/2025 | 209.21 K | $224.90 K | 0.00% | 1.81% |
| MORGAN STANLEY | 11/14/2025 | 130.57 K | $140.37 K | -0.49% | 1.13% |
| BLACKROCK, INC. | 11/12/2025 | 116.13 K | $124.84 K | 0.00% | 1.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 109.08 K | $115.66 K | 0.00% | 0.94% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2025 | 35.50 K | $38.16 K | 138.26% | 0.31% |
| CITADEL ADVISORS LLC | 11/14/2025 | 34.27 K | $36.33 K | 100.00% | 0.30% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 11/14/2025 | 34.00 K | $36.04 K | 0.00% | 0.29% |
| STATE STREET CORP | 11/14/2025 | 30.10 K | $31.91 K | 0.00% | 0.26% |
| NORTHERN TRUST CORP | 11/14/2025 | 16.46 K | $17.69 K | 0.00% | 0.14% |
| J. GOLDMAN & CO LP | 11/14/2025 | 13.56 K | $14.58 K | 0.00% | 0.12% |
| TWO SIGMA SECURITIES, LLC | 11/14/2025 | 11.97 K | $12.87 K | 14.67% | 0.10% |
| FMR LLC | 11/13/2025 | 8.29 K | $8.79 K | 0.00% | 0.07% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 11/14/2025 | 2.73 K | $2.94 K | -5.17% | 0.02% |
| ADVISOR GROUP HOLDINGS, INC. | 11/14/2025 | 897 | $972 | 4.18% | 0.01% |
| NATIONAL BANK OF CANADA /FI/ | 11/14/2025 | 670 | $710 | -5.63% | 0.01% |
| UBS GROUP AG | 11/13/2025 | 362 | $390 | -91.96% | 0.00% |
| JPMORGAN CHASE & CO | 11/26/2025 | 293 | $310 | 0.00% | 0.00% |
| SBI SECURITIES CO., LTD. | 11/05/2025 | 255 | $274 | 0.00% | 0.00% |
| US BANCORP \DE\ | 11/12/2025 | 246 | $264 | 0.00% | 0.00% |
| BNP PARIBAS ARBITRAGE, SNC | 11/13/2025 | 226 | $243 | 0.00% | 0.00% |
| HUNTINGTON NATIONAL BANK | 11/12/2025 | 120 | $129 | 0.00% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 106 | $114 | -79.62% | 0.00% |
| BARCLAYS PLC | 11/12/2025 | 44 | $47 | 100.00% | 0.00% |
| ACTIVEST WEALTH MANAGEMENT | 11/03/2025 | 40 | $43 | 0.00% | 0.00% |
| WELLS FARGO & COMPANY/MN | 11/13/2025 | 37 | $40 | -35.09% | 0.00% |
| STEWARD PARTNERS INVESTMENT ADVISORY, LLC | 11/12/2025 | 35 | $38 | -2.78% | 0.00% |
| FARTHER FINANCE ADVISORS, LLC | 10/14/2025 | 30 | $32 | 0.00% | 0.00% |
| WEALTH WATCH ADVISORS, INC | 11/13/2025 | 22 | $24 | 100.00% | 0.00% |
| IFP ADVISORS, INC | 12/02/2025 | 21 | $23 | 0.00% | 0.00% |
| PROVENANCE WEALTH ADVISORS, LLC | 11/12/2025 | 20 | $22 | 0.00% | 0.00% |
| ADVISORY SERVICES NETWORK, LLC | 11/18/2025 | 14 | $15 | 100.00% | 0.00% |
| TRUVESTMENTS CAPITAL LLC | 11/14/2025 | 10 | $11 | 0.00% | 0.00% |
| HARBOUR INVESTMENTS, INC. | 11/12/2025 | 8 | $9 | 0.00% | 0.00% |
| ASSETMARK, INC | 11/06/2025 | 4 | $4 | 0.00% | 0.00% |
| SMALLWOOD WEALTH INVESTMENT MANAGEMENT, LLC | 10/17/2025 | 2 | $2 | 0.00% | 0.00% |
| CITIGROUP INC | 11/10/2025 | 1 | $1 | -99.51% | 0.00% |
| NEWEDGE ADVISORS, LLC | 11/17/2025 | 1 | $1 | 0.00% | 0.00% |
| EVERSOURCE WEALTH ADVISORS, LLC | 11/10/2025 | 1 | $1 | 0.00% | 0.00% |
| STRATEGIC ADVOCATES LLC | 11/26/2025 | 1 | $1 | 100.00% | 0.00% |
| RAYMOND JAMES FINANCIAL INC | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
| CITADEL ADVISORS LLC | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
TherapeuticsMD, Inc. institutional Ownership - FAQ's
During the previous two years, 48 institutional investors and hedge funds held shares of TherapeuticsMD, Inc.. The most heavily invested institutionals were:
Rubric Capital Management LP: 1.19 M
Clearline Capital LP: 635,222
VANGUARD GROUP INC: 376,828
Tejara Capital Ltd: 344,203
ADAR1 Capital Management, LLC: 209,210
MORGAN STANLEY: 130,572
28.54% of TherapeuticsMD, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 3.48 M shares in the last 24 months. This purchase volume represents approximately $3.76 M in transactions.